Concepedia

Publication | Open Access

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

DOIFull Paper Access

17

Citations

9

References

2016

Year

Daniele Santini, Matteo Santoni, Alessandro Conti, Giuseppe Procopio, Elena Verzoni, Luca Galli, Giuseppe Di Lorenzo, Ugo De Giorgi, Delia De Lisi, Maurizio Nicodemo,
Oncotarget

Abstract

The prognostic value of CR depends on the site where was obtained and how was obtained (with or without locoregional treatment). Cessation of TKI should be carefully considered in complete responder patients.

References

YearCitations

Page 1